259 related articles for article (PubMed ID: 20408342)
1. Glatiramer acetate: successful desensitization for treatment of multiple sclerosis.
Bains SN; Hsieh FH; Rensel MR; Radojicic C; Katz HT; Inamdar SR; Lang DM
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):321-5. PubMed ID: 20408342
[TBL] [Abstract][Full Text] [Related]
2. [Long-term effects of glatiramer acetate in multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
[TBL] [Abstract][Full Text] [Related]
3. Desensitization to imatinib in patients with leukemia.
Nelson RP; Cornetta K; Ward KE; Ramanuja S; Fausel C; Cripe LD
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):216-22. PubMed ID: 16937754
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of glatiramer acetate in clinical practice: an observational study.
Fernández-Fernández Ó; Garcia-Trujillo L; Guerrero-Fernández M; León A; López-Madrona JC; Alonso A; Bustamante R; Fernández-Sánchez VE
Rev Neurol; 2012 Jan; 54(1):1-9. PubMed ID: 22187206
[TBL] [Abstract][Full Text] [Related]
5. Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.
Comi G; Cohen JA; Arnold DL; Wynn D; Filippi M;
Ann Neurol; 2011 Jan; 69(1):75-82. PubMed ID: 21280077
[TBL] [Abstract][Full Text] [Related]
6. Allergy workup in immediate-type local reactions to glatiramer acetate.
Sánchez-López J; Rodríguez del Rio P; Cases-Ortega B; Martínez-Cócera C; Fernández-Rivas M
J Investig Allergol Clin Immunol; 2010; 20(6):521-3. PubMed ID: 21243937
[TBL] [Abstract][Full Text] [Related]
7. Modified protocol for desensitization to glatiramer acetate.
Sheth SS; Posner MA
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):190. PubMed ID: 20674837
[No Abstract] [Full Text] [Related]
8. Endermology: a treatment for injection-induced lipoatrophy in multiple sclerosis patients treated with sub cutaneous glatiramer acetate.
Lebrun C; Mondot L; Bertagna M; Calleja A; Cohen M
Clin Neurol Neurosurg; 2011 Nov; 113(9):721-4. PubMed ID: 21839580
[TBL] [Abstract][Full Text] [Related]
9. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases.
Ball NJ; Cowan BJ; Moore GR; Hashimoto SA
J Cutan Pathol; 2008 Apr; 35(4):407-10. PubMed ID: 18333902
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer: new preparation. No place in multiple sclerosis.
Prescrire Int; 2004 Feb; 13(69):10-2. PubMed ID: 15055208
[TBL] [Abstract][Full Text] [Related]
11. Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Mayorga C; Blazquez AB; Doña I; Gomez F; Chaves P; Sanchez-Quintero MJ; Blanca-López N; Melendez L; Blanca M; Torres MJ
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):47-51. PubMed ID: 22727157
[TBL] [Abstract][Full Text] [Related]
12. Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: a clinicopathologic and immunohistochemical study.
Soares Almeida LM; Requena L; Kutzner H; Angulo J; de Sa J; Pignatelli J
J Am Acad Dermatol; 2006 Dec; 55(6):968-74. PubMed ID: 17097393
[TBL] [Abstract][Full Text] [Related]
13. The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS.
Pöllmann W; Erasmus LP; Feneberg W; Straube A
Neurology; 2006 Jan; 66(2):275-7. PubMed ID: 16434675
[TBL] [Abstract][Full Text] [Related]
14. Link of the mechanisms of action of glatiramer acetate to its long-term clinical data.
Moreau T
J Neurol Sci; 2009 Feb; 277 Suppl 1():S12-5. PubMed ID: 19200858
[TBL] [Abstract][Full Text] [Related]
15. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.
Castelli-Haley J; Oleen-Burkey M; Lage MJ; Johnson KP
Adv Ther; 2008 Jul; 25(7):658-73. PubMed ID: 18641926
[TBL] [Abstract][Full Text] [Related]
16. Lessons from randomised direct comparative trials.
Achiron A; Fredrikson S
J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
[TBL] [Abstract][Full Text] [Related]
17. Successful Rapid Desensitization to Glatiramer Acetate in a Patient With Multiple Sclerosis.
Syrigou E; Psarros P; Grapsa D; Syrigos K
J Investig Allergol Clin Immunol; 2015; 25(3):214-5. PubMed ID: 26182688
[No Abstract] [Full Text] [Related]
18. Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis.
Kornek B; Bernert G; Balassy C; Geldner J; Prayer D; Feucht M
Neuropediatrics; 2003 Jun; 34(3):120-6. PubMed ID: 12910434
[TBL] [Abstract][Full Text] [Related]
19. Desensitization in interferon-beta1a allergy: a case report.
Fusun Kalpaklioglu A; Baccioglu Kavut A; Erdemoglu AK
Int Arch Allergy Immunol; 2009; 149(2):178-80. PubMed ID: 19127077
[TBL] [Abstract][Full Text] [Related]
20. Systemic reaction to glatiramer acetate.
Bayerl C; Bohland P; Jung EG
Contact Dermatitis; 2000 Jul; 43(1):62-3. PubMed ID: 10902605
[No Abstract] [Full Text] [Related]
[Next] [New Search]